Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

14 results
Display

Corrigendum: Randomized, crossover questionnaire survey of acceptabilities of controlled-release mesalazine tablets and granules in ulcerative colitis patients

Yagisawa K, Kobayashi T, Ozaki R, Okabayashi S, Toyonaga T, Miura M, Hayashida M, Saito E, Nakano M, Matsubara H, Hisamatsu T, Hibi T

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Education levels and survival in colorectal cancer: is there really an obvious association?

Valiati B, Perez RO, Kotze PG

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?

Oh GM, Moon W

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Capsule endoscopy in inflammatory bowel disease: when and how

Hilmi I, Kobayashi T

Capsule endoscopy (CE) is emerging as an important investigation in inflammatory bowel disease (IBD); common types include the standard small bowel CE and colon CE. More recently, the pan-enteric CE...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Melatonin in the colon modulates intestinal microbiota in response to stress and sleep deprivation

Park YS, Kim SH, Park JW, Kho Y, Seok PR, Shin JH, Choi YJ, Jun JH, Jung HC, Kim EK

Background/Aims: Stress is closely related to the deterioration of digestive disease. Melatonin has potent anti-inflammatory properties. The objective of this study was to determine the effect of water stress (WS)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease

Matsuoka K

Thiopurine has been used to maintain remission and to reduce antidrug antibody formation in monoclonal antibody therapy in patients with inflammatory bowel disease (IBD). The use of thiopurine is limited...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sausage-like fingers in Crohn’s disease

Hokama A, Miyagi T, Takeichi Y, Uema E, Takehara S, Ohira T, Iraha A, Kinjo T, Fujita J

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Factors associated with the survival of colorectal cancer in Mexico

Quezada-Gutiérrez C, Álvarez-Bañuelos MT, Morales-Romero J, Sampieri CL, Guzmán-García RE, Montes-Villaseñor E

Background/Aims: Colorectal cancer (CRC) is a public health problem. In Mexico, there have been no recent studies conducted on survival in terms of this pathology or on the influence of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incidental benefits after fecal microbiota transplant for ulcerative colitis

Mahajan R, Midha V, Singh A, Mehta V, Gupta Y, Kaur K, Sudhakar R, Singh Pannu A, Singh D, Sood A

Gut dysbiosis can result in several diseases, including infections (Clostridium difficile infection and infectious gastroenteritis), autoimmune diseases (inflammatory bowel disease, diabetes, and allergic disorders), behavioral disorders and other conditions like...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases

Kim JM, Cheon JH

A considerable number of patients with inflammatory bowel disease (IBD) experience extraintestinal manifestations (EIMs), which can present either before or after IBD diagnosis. Unraveling the pathogenic pathways of EIMs in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancy

Phan H, Weideman RA, Cipher DJ, Feagins LA

Background/Aims: Safety for tumor necrosis factor inhibitors (TNFi) in cancer has been focused on risk of incident malignancies, but studies on prognostic effects have been scarce. We determined survival and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease

Alrajhi S, Germain P, Martel M, Lakatos P, Bessissow T, Al-Taweel T, Afif W

Background/Aims: Latent tuberculosis screening is mandatory prior to initiating anti-tumor necrosis factor (anti-TNF) medications. Guidelines recommend interferon-gamma release assays (IGRA) as first line screening method for the general population. Studies...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypermethylated promoters of tumor suppressor genes were identified in Crohn’s disease patients

Kim TO, Han YK, Yi JM

Background/Aims: Overwhelming evidence suggests that inflammatory bowel disease (IBD) is caused by a complicated interplay between the multiple genes and abnormal epigenetic regulation in response to environmental factors. It is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Presentation and outcomes among inflammatory bowel disease patients with concurrent pneumatosis intestinalis: a case series and systematic review

Gao Y, Uffenheimer M, Ashamallah M, Grimaldi G, Swaminath A, Sultan K

Background/Aims: Inflammatory bowel disease (IBD) involves chronic inflammation of the colon with ulcerative colitis (UC), and the colon and/or small intestine with Crohn’s disease (CD). Pneumatosis intestinalis (PI), characterized by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr